Skip to main content
PYXS
NASDAQ Life Sciences

Pyxis Oncology Extends Cash Runway to Q2 2027, Sets Fall Data Readouts for MICVO

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.12
Mkt Cap
$201.47M
52W Low
$1
52W High
$5.55
52W Position info
212% above low
Off High info
44% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

PYXS has more than doubled off its 52-week low of $1.

Summary

Pyxis Oncology reported Q2 2026 results and provided updated clinical timelines for its lead asset MICVO. The company now expects to report updated monotherapy data in 2L+ R/M HNSCC in Fall 2026, including detailed dose cap analyses, and combination data with pembrolizumab in Q4 2026. The recent $50M upfront private placement, combined with existing cash, extends the runway into Q2 2027, a meaningful improvement from the prior Q4 2026 estimate. This follows the July 2 completion of the financing and addresses the going concern risk highlighted in the last 10-Q. The extended runway and near-term data catalysts position the company for potential value inflection, though the data readouts remain binary events.

Updates

  1. · SEC 10-Q — The 10-Q reports cash, cash equivalents, and marketable debt securities of $33.0 million as of June 30, 2026, and a net loss of $25.3 million for Q2 2026.

At the time of this announcement, PYXS was trading at $3.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $201.5M. The 52-week trading range was $1.00 to $5.55. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PYXS - Latest Insights

PYXS
Nov 19, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.80 info
Change: +$0.300 (+20%) info
Market Cap: $215.294M info
PYXS
Nov 18, 2026, 6:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.46
Real-time Price: $1.80 info
Change: +$0.340 (+23%) info
Market Cap: $215.294M info
PYXS
Nov 13, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.80 info
Change: +$0.220 (+14%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:39 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info